97 related articles for article (PubMed ID: 19639208)
1. Diagnostic relevance of overexpressed Nanog gene in early lung cancers.
Nirasawa S; Kobayashi D; Tsuji N; Kuribayashi K; Watanabe N
Oncol Rep; 2009 Sep; 22(3):587-91. PubMed ID: 19639208
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic relevance of overexpressed mRNA of novel oncogene with kinase-domain (NOK) in lung cancers.
Amachika T; Kobayashi D; Moriai R; Tsuji N; Watanabe N
Lung Cancer; 2007 Jun; 56(3):337-40. PubMed ID: 17298854
[TBL] [Abstract][Full Text] [Related]
3. Nanog, a novel prognostic marker for lung cancer.
Du Y; Ma C; Wang Z; Liu Z; Liu H; Wang T
Surg Oncol; 2013 Dec; 22(4):224-9. PubMed ID: 24018162
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of SALL4 in lung cancer and its importance in cell proliferation.
Kobayashi D; Kuribayashi K; Tanaka M; Watanabe N
Oncol Rep; 2011 Oct; 26(4):965-70. PubMed ID: 21725617
[TBL] [Abstract][Full Text] [Related]
5. Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.
Habu N; Imanishi Y; Kameyama K; Shimoda M; Tokumaru Y; Sakamoto K; Fujii R; Shigetomi S; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Fujii M; Ogawa K
BMC Cancer; 2015 Oct; 15():730. PubMed ID: 26483189
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells.
Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH
Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959
[TBL] [Abstract][Full Text] [Related]
7. Functional evidence that the self-renewal gene NANOG regulates human tumor development.
Jeter CR; Badeaux M; Choy G; Chandra D; Patrawala L; Liu C; Calhoun-Davis T; Zaehres H; Daley GQ; Tang DG
Stem Cells; 2009 May; 27(5):993-1005. PubMed ID: 19415763
[TBL] [Abstract][Full Text] [Related]
8. SALL4 is essential for cancer cell proliferation and is overexpressed at early clinical stages in breast cancer.
Kobayashi D; Kuribayshi K; Tanaka M; Watanabe N
Int J Oncol; 2011 Apr; 38(4):933-9. PubMed ID: 21274508
[TBL] [Abstract][Full Text] [Related]
9. Increased Nanog expression promotes tumor development and Cisplatin resistance in human esophageal cancer cells.
Yang L; Zhang X; Zhang M; Zhang J; Sheng Y; Sun X; Chen Q; Wang LX
Cell Physiol Biochem; 2012; 30(4):943-52. PubMed ID: 23221432
[TBL] [Abstract][Full Text] [Related]
10. Expression of seven stem-cell-associated markers in human airway biopsy specimens obtained via fiberoptic bronchoscopy.
Li L; Yu H; Wang X; Zeng J; Li D; Lu J; Wang C; Wang J; Wei J; Jiang M; Mo B
J Exp Clin Cancer Res; 2013 May; 32(1):28. PubMed ID: 23683495
[TBL] [Abstract][Full Text] [Related]
11. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.
Chiou SH; Wang ML; Chou YT; Chen CJ; Hong CF; Hsieh WJ; Chang HT; Chen YS; Lin TW; Hsu HS; Wu CW
Cancer Res; 2010 Dec; 70(24):10433-44. PubMed ID: 21159654
[TBL] [Abstract][Full Text] [Related]
12. NANOG maintains self-renewal of primate ES cells in the absence of a feeder layer.
Yasuda SY; Tsuneyoshi N; Sumi T; Hasegawa K; Tada T; Nakatsuji N; Suemori H
Genes Cells; 2006 Sep; 11(9):1115-23. PubMed ID: 16923129
[TBL] [Abstract][Full Text] [Related]
13. Id1 maintains embryonic stem cell self-renewal by up-regulation of Nanog and repression of Brachyury expression.
Romero-Lanman EE; Pavlovic S; Amlani B; Chin Y; Benezra R
Stem Cells Dev; 2012 Feb; 21(3):384-93. PubMed ID: 22013995
[TBL] [Abstract][Full Text] [Related]
14. Specific overexpression of OLFM4(GW112/HGC-1) mRNA in colon, breast and lung cancer tissues detected using quantitative analysis.
Koshida S; Kobayashi D; Moriai R; Tsuji N; Watanabe N
Cancer Sci; 2007 Mar; 98(3):315-20. PubMed ID: 17270020
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic importance of overexpression of Bmi-1 mRNA in early breast cancers.
Saeki M; Kobayashi D; Tsuji N; Kuribayashi K; Watanabe N
Int J Oncol; 2009 Sep; 35(3):511-5. PubMed ID: 19639171
[TBL] [Abstract][Full Text] [Related]
16. Analysis of co-expression of OCT4, NANOG and SOX2 in pluripotent cells of the porcine embryo, in vivo and in vitro.
du Puy L; Lopes SM; Haagsman HP; Roelen BA
Theriogenology; 2011 Feb; 75(3):513-26. PubMed ID: 21074831
[TBL] [Abstract][Full Text] [Related]
17. Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer.
Tanabe H; Yagihashi A; Tsuji N; Shijubo Y; Abe S; Watanabe N
Lung Cancer; 2004 Dec; 46(3):299-304. PubMed ID: 15541814
[TBL] [Abstract][Full Text] [Related]
18. Involvement of NANOG upregulation in malignant progression of human cells.
Li Y; Higashiyama S; Shimakage M; Kawahara K; Yutsudo M; Watari A
DNA Cell Biol; 2013 Mar; 32(3):104-10. PubMed ID: 23427894
[TBL] [Abstract][Full Text] [Related]
19. Identification of genes regulated by nanog which is involved in ES cells pluripotency and early differentiation.
Liu N; Feng X; Fang Z; Ma F; Lu S; Lu M; Han Z
J Cell Biochem; 2008 Aug; 104(6):2348-62. PubMed ID: 18442017
[TBL] [Abstract][Full Text] [Related]
20. Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma.
Shan J; Shen J; Liu L; Xia F; Xu C; Duan G; Xu Y; Ma Q; Yang Z; Zhang Q; Ma L; Liu J; Xu S; Yan X; Bie P; Cui Y; Bian XW; Qian C
Hepatology; 2012 Sep; 56(3):1004-14. PubMed ID: 22473773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
